#Novartis charging in the race for #generics
The big boys of pharmaceuticals are well on the generics wagon as Novartis announces the US introduction of Hecoria (tacrolimus) capsules, the..
Are you concerned with reducing the cost, time and risk of drug development whilst refilling your R&D pipeline? Drug repositioning: As the cost and time of drug development persistently increases, drug repositioning..
The big boys of pharmaceuticals are well on the generics wagon as Novartis announces the US introduction of Hecoria (tacrolimus) capsules, the..
At the Pharma Manufacturing World Asia 2012, Pfizer's Director of Operations Management and Operational Excellence, Kim Sandell gave an interesting..
Vikas Namjoshi from Eisai gave a talked to an enthralled room about how Eisai had a well define plan when it came to designing their manufacturing..
It is no secret that the biopharma industry in general produces a lot of paper documentation. The industry, understandably it would have to..
At the Biologic Manufacturing World Asia, Wassim Nashabeh from Genentech Inc was telling the room about how comparibility was revolutionising..
ClinActis Pte Ltd will participate in the BioPharma Asia Convention 2012 which will take place in Singapore from March 19th to March 22nd,..
Contributed by Biotec: UK based pharmaceutical services business Biotec Services International has launched a dedicated new storage and operational..
Supera Farma Laboratorios, co-owned by Cristalia Produtos Quimicos Farmaceuticos and Eurofarma Laboratorios, teamed up with Merck & Co...
Government should support generics industry Both the Medical Journal of Australia and the Australian Generic Medicines Industry Association..
© terrapinn holdings ltd. MMX | images courtesy of SXC | terms & conditions | privacy | log in
